Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HC.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
AY.93 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.93 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.93 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.31.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.31.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.31.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
GW.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
FL.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BW.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BW.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.312NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.312NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.312NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.220NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.220NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.220NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.142NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.142NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.142NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.523NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.523NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.523NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used